Akcea Therapeutics Inc. (AKCA)

Trade AKCA now with
8/31/2020 6:56:39 AM Ionis To Buy Remaining 24% Of Common Stock Of Akcea It Does Not Already Own For $18.15/Shr Cash
8/13/2020 7:06:47 AM Akcea Announces New Pricing And Reimbursement Of WAYLIVRA In Germany
7/22/2020 7:10:20 AM Akcea Gets Approval For Reimbursement Of TEGSEDI In Austria For Hereditary Transthyretin Amyloidosis With Polyneuropathy
6/29/2020 7:04:29 AM Akcea Appoints Tracy Palmer Berns As Chief Compliance Officer
6/9/2020 7:02:06 AM Akcea Appoints Kia Motesharei As New SVP, Business Development And Corporate Strategy
5/18/2020 7:01:59 AM Akcea Therapeutics Names Michael Price EVP And CFO
5/13/2020 8:10:29 AM Akcea Therapeutics Canada Confirms LoI With Pan-Canadian Pharmaceutical Alliance For TEGSEDI
3/24/2020 7:07:51 AM Akcea Therapeutics Appoints Damien McDevitt As CEO
3/13/2020 7:07:30 AM Akcea Therapeutics Canada Celebrates Official Launch Of First-of-its-kind Research Grant Program
3/11/2020 7:23:23 AM Akcea Therapeutics Names Lisa Johnson-Pratt SVP Of New Product Strategy; Promotes Joshua Patterson To General Counsel
1/22/2020 7:09:37 AM Akcea And Ionis Announce Positive Topline Phase 2 Results Of AKCEA-APOCIII-L Rx
1/10/2020 7:02:55 AM Akcea And Ionis Begin CARDIO-TTRansform Phase 3 Clinical Trial For AKCEA-TTR-LRx